U.K. Healthcare Big Green Snowflakes

Tristel

Market Cap: UK£151.7m

Develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally.

Smith & Nephew

Market Cap: UK£8.7b

Develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally.

Integrated Diagnostics Holdings

Market Cap: US$209.3m

A consumer healthcare company, provides various medical diagnostics services to patients.

ConvaTec Group

Market Cap: UK£5.3b

Engages in the development, manufacturing, and sale of medical products, services and technologies in Europe, North America, and internationally.

NIOX Group

Market Cap: UK£238.0m

Engages in the design, development, and commercialization of medical devices for asthma diagnosis, monitoring, and management worldwide.

Craneware

Market Cap: UK£539.3m

Develops, licenses, and supports computer software for the healthcare industry in the United States.

Kooth

Market Cap: UK£46.9m

Provides digital mental health services to children, young people, and adults in the United Kingdom.

EKF Diagnostics Holdings

Market Cap: UK£97.7m

Engages in the design, development, manufacture, and sale of diagnostic instruments, reagents, and other ancillary products in Europe, the Middle East, the Americas, Asia, Africa, and internationally.

INSPECS Group

Market Cap: UK£41.7m

Designs, produces, sells, markets, and distributes fashion eyewear, lenses, and OEM products worldwide.

Advanced Medical Solutions Group

Market Cap: UK£412.9m

Develops, manufactures, and distributes products for the surgical, woundcare, and wound-closure markets in the United Kingdom, Germany, rest of Europe, the United States, and internationally.

PHSC

Market Cap: UK£1.6m

Through its subsidiaries, provides health, safety, hygiene, and environmental consultancy services and security solutions to the public and private sectors in the United Kingdom.

Belluscura

Market Cap: UK£3.0m

Develops and commercialize oxygen related medical device products in the United States.

Inspiration Healthcare Group

Market Cap: UK£15.0m

Designs, manufactures, and sells medical technology products worldwide.

Feedback

Market Cap: UK£6.9m

A medical imaging technology company, engages in the provision of software and systems to those working in the field of medical imaging.

GENinCode

Market Cap: UK£7.2m

Develops and commercializes clinical genetic tests to provide predictive analysis of risk to a patient’s health based on their genes in the United Kingdom and internationally.

CVS Group

Market Cap: UK£707.4m

Engages in veterinary, pet crematoria, online pharmacy, and retail businesses.

Induction Healthcare Group

Market Cap: UK£8.9m

Provides software to healthcare professionals in the United Kingdom.

Abingdon Health

Market Cap: UK£22.6m

Operates as contract research, and contract development and manufacturing organization that develops, manufactures, and distributes diagnostic devices in the United Kingdom, the United States, Canada, Europe, and internationally.

Spire Healthcare Group

Market Cap: UK£737.9m

Owns and operates private hospitals and clinics in the United Kingdom.

ANGLE

Market Cap: UK£25.8m

A medical diagnostic company, engages in developing cancer diagnostics products in the United Kingdom, Europe, North America, and internationally.

Polarean Imaging

Market Cap: UK£12.4m

Operates as a drug-device manufacturer and service provider for noble gas polariser devices in Canada, the United Kingdom, and the United States.

Trellus Health

Market Cap: UK£3.0m

Provides digital chronic condition management solutions for employers and health plans.

Optima Health

Market Cap: UK£155.4m

Provides occupational health and wellbeing services for the public and private sectors in the United Kingdom.

Cambridge Nutritional Sciences

Market Cap: UK£6.4m

Develops, manufactures, and distributes medical diagnostics products for the food sensitivity testing market in the United Kingdom, rest of Europe, North America, South/Central America, India, rest of Asia and the Far East, Africa, and the Middle East.

Cambridge Cognition Holdings

Market Cap: UK£14.4m

A neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally.

Ondine Biomedical

Market Cap: UK£42.1m

A life-sciences company, engages in the development and commercialization of antimicrobial therapies in Canada and internationally.

RUA Life Sciences

Market Cap: UK£7.0m

Engages in the provision of polymers, services, and products to the medical device industry in Europe, the United States, and internationally.

Totally

Market Cap: UK£8.4m

Provides healthcare services in the United Kingdom and Ireland.

TruSpine Technologies

Market Cap: UK£956.4k

A medical device company, engages in the development of spinal stabilization products in the United Kingdom and the United States.

Creo Medical Group

Market Cap: UK£39.6m

Through its subsidiaries, engages in the research, development, manufacture, and sale of medical devices and instruments in the United Kingdom.

Surgical Innovations Group

Market Cap: UK£4.7m

Engages in the design, manufacture, and export of medical products for use in laparoscopic and robotic minimally invasive surgery in the United Kingdom, Europe, the Asia Pacific, the United States, and internationally.

EMV Capital

Market Cap: UK£10.7m

A venture capital firm specializing in seed, growth capital, early and mid stage investments.

MyHealthChecked

Market Cap: UK£7.3m

Develops, distributes, and commercializes at-home healthcare and wellness tests in the United Kingdom.

IQ-AI

Market Cap: UK£2.1m

Through its subsidiaries, provides clinical treatments to patients in the field of medical imaging diagnostics primarily in the United States.

CRUSHMETRIC Group

Market Cap: UK£30.2m

A design and production company, integrates shape changing technology into catalogue of products in Hong Kong, Mainland China, and Singapore.

Renalytix

Market Cap: UK£26.5m

Develops artificial intelligence-enabled in vitro diagnostic solutions for clinical management kidney diseases in the United States.